Contact this trialFirst, we need to learn more about you.
Annuloplasty Ring
Percutaneous Ring Annuloplasty for Tricuspid Regurgitation
Recruiting1 award10 criteria
New York, New York
This trial is testing a new device to treat tricuspid regurgitation, a heart valve disease. The device is implanted using a catheter, a thin tube inserted through a vein. The study will evaluate the safety and effectiveness of the device, as well as how well it works after being adjusted about 90 days after implantation.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.